[Expert consensus on the management of B-cell lymphoma-related cardiovascular diseases with Bruton tyrosine kinase inhibitors (2023)]

Zhonghua Xue Ye Xue Za Zhi. 2023 May 14;44(5):359-365. doi: 10.3760/cma.j.issn.0253-2727.2023.05.002.

[Article in Chinese]

Authors

Hematological Oncology Committee of China Anti-Cancer Association; Chinese Society of Hematology, Chinese Medical Association; Chinese Workshop on Chronic Lymphocytic Leukemia

PMID: 37550184
PMCID: PMC10440626
DOI: 10.3760/cma.j.issn.0253-2727.2023.05.002

No abstract available

MeSH terms

Cardiovascular Diseases* / drug therapy
Consensus
Humans
Lymphoma, B-Cell*
Lymphoma, Mantle-Cell*
Tyrosine Kinase Inhibitors* / therapeutic use

Substances

Tyrosine Kinase Inhibitors